[Association for ankylosing spondylarthritis multiple myeloma. A case history (author's transl)].
The authors describe a patient treated 16 years by phenylbutazone for ankylosing spondylarthritis and in whom appeared an IgA multiple myeloma with a Kappa light chain. This pathological association is rare and we can wonder about the respective etiopathological roles of spondylarthritis and its treatment by phenylbutazone in the occurrence of multiple myeloma.
D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis; D007145:Immunoglobulin kappa-Chains / Q000096:biosynthesis; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000276:immunology; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000150:complications* / Q000188:drug therapy
D007070:Immunoglobulin A; D007145:Immunoglobulin kappa-Chains; D010653:Phenylbutazone
Association spondylarthrite ankylosante maladie de Kahler. A propos d'une observation.